Skip to main content
Caplight Logo









Visualise.bio

Visualise.bio

Private
AmsterdamHealthcare & Life Scienceshttps://visualise.bio

Last Round

Pre Seed

Jun 11, 2026

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Visualise.bio operates in Healthcare & Life Sciences and is based in Amsterdam. It was founded in 2024.

Visualise.bio is a life-science technology company that develops automated expansion microscopy solutions to standardize and improve the reproducibility of high-resolution 3D imaging.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Medical Imaging, Biotechnology, Quality Management

Business Model

B2B

Customer Profile

Hardware Sales, Data as a Service

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Visualise.bio Comparables

Compare Visualise.bio with similar companies based on industry and business-model similarity.

Visualise.bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Magnify Biosciences
82%
Panluminate, Inc.
78%
Expansion Technologies, Inc.
76%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Visualise.bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedJun 11, 2026
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Visualise.bio Investors

Notable investors and investment history

Visualise.bio investors
InvestorRounds
Graduate EntrepreneurPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 11, 2026

    Raised a Pre Seed round with Graduate Entrepreneur as an investor.

Book a demo to see all signals

For institutional investors. Book with your work email.

Visualise.bio Filings

Explore SEC and related filing metadata, where available.

Visualise.bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Visualise.bio's valuation, stock price, and market status.

Is Visualise.bio a public or private company?

Visualise.bio is a private company.

What is the current stock price of Visualise.bio?

Visualise.bio is a private company, so its shares have no public market price. Caplight tracks Visualise.bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Visualise.bio worth (valuation)?

Valuation information for Visualise.bio is not publicly available.

Can I buy Visualise.bio stock?

Visualise.bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Visualise.bio's last funding round?

Visualise.bio's most recent funding round was Pre Seed on June 11, 2026.

Who are the main investors in Visualise.bio?

Key investors in Visualise.bio include Graduate Entrepreneur.

Will Visualise.bio IPO soon?

No public IPO plans have been announced for Visualise.bio.

How can I track Visualise.bio secondary market activity?

Caplight tracks bids, offers, and trades in Visualise.bio's shares on secondary markets.

Firmographic Details

HeadquartersAmsterdam
Year Founded2024
Last FundingJun 11, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?